CMO and CDMO biotechnology Market

CMO and CDMO biotechnology Market aims to provide a comprehensive presentation of the global market for CMO and CDMO biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO and CDMO biotechnology. CMO and CDMO biotechnology Market contains market size and forecasts of CMO and CDMO biotechnology in global, including the following market information:

Global CMO and CDMO biotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global CMO and CDMO biotechnology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

Service Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of CMO and CDMO biotechnology include Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the CMO and CDMO biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CMO and CDMO biotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global CMO and CDMO biotechnology Market Segment Percentages, by Type, 2022 (%)

Service

Product

Platform/ Expression System

Global CMO and CDMO biotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global CMO and CDMO biotechnology Market Segment Percentages, by Application, 2022 (%)

Large Enterprise

SME

Global CMO and CDMO biotechnology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global CMO and CDMO biotechnology Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CMO and CDMO biotechnology revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies CMO and CDMO biotechnology revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Patheon

Catalent

Samsung Biologics

Lonza.

Boehringer Ingelheim

Samsung BioLogics

AGC Biologics

WuXi Biologics

AbbVie

Avid Bioservices

Fujifilm Diosynth Biotechnologies

KBI Biopharma (JSR Corporation)

Cytovance Biologics

Xpress Biologic

Rentschler Biopharma

Outline of Major Chapters:

Chapter 1: Introduces the definition of CMO and CDMO biotechnology, market overview.

Chapter 2: Global CMO and CDMO biotechnology market size in revenue.

Chapter 3: Detailed analysis of CMO and CDMO biotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of CMO and CDMO biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.